Evaluating performance of HealthCubedâ??s AgeWell device

Clinical validation of HealthCubedâ??s AgeWell device- a patient monitoring system for measuring vital parameters

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2021/01/030427

Enrollment

Registered

2021-01-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL Control Intervention3: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of any sex, 18 years and older, can be enrolled in this study. 2. Subjects must consent to participating in the study.

Exclusion criteria

Exclusion criteria: â?? Pregnant women â?? Smokers â?? Individuals subject to conditions that result in elevated levels of methaemoglobin â?? Subjects exhibiting injuries, intravenous lines, or other abnormalities that, in the opinion of the investigator, may prevent proper cuff application or functioning. â?? Subjects with compromised circulation or peripheral vascular disease â?? Subjects with clotting disorders or taking blood thinners

Design outcomes

Primary

Measure	Time frame
Assessment of performance of AgeWell Device in comparison to Philips SureSignsTimepoint: 2 weeks	—

Secondary

Measure	Time frame
Feedback from usability perspective by study performed over 50 subjectsTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactDr Radha Rangarajan

HealthCubed India Private Limited

radha@healthcubed.com

Outcome results